Chester County News and Community Website
DOWNINGTOWN, PA — Hundreds of students from the Downingtown Area School District (DASD) and surrounding schools gathered for the annual Cam-A-Thon, raising an impressive $45,766.41 for Alex’s Lemonade Stand Foundation, …
Downingtown Students Raise Over $45,000 for Childhood Cancer Research Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) and its NCCN Foundation® have announced the recipients of the 2025 Young Investigator Awards (YIA). This initiative provides critical funding …
NCCN Foundation Awards Bolster Breakthrough Cancer Research Read More
PHILADELPHIA, PA — FORE Biotherapeutics has announced that two abstracts on its investigational therapy plixorafenib will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. …
FORE Biotherapeutics to Present Plixorafenib Research at AACR Annual Meeting Read More
PHILADELPHIA, PA — Celebrating 25 years since its founding, Alex’s Lemonade Stand Foundation (ALSF) has announced the funding of two pioneering research projects aimed at transforming early detection and prevention of …
Alex’s Lemonade Stand Foundation Marks 25th Anniversary With Groundbreaking Cancer Research Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a Clinical Trial?” to address common questions and misconceptions about …
NCCN Launches Free On-Demand Webinar on Cancer Clinical Trials Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced the awarding of three new grants to advance clinical research in gastrointestinal cancers. The funding, …
NCCN Awards Grants to Advance Research in Gastrointestinal Cancer Treatment Read More
PHILADELPHIA, PA— Researchers at The Wistar Institute, led by Jessie Villanueva, Ph.D., have made significant strides in combating treatment-resistant melanoma. Their latest discovery focuses on inhibiting the gene S6K2, a breakthrough …
Wistar Institute Uncovers New Strategy for Treating Resistant Melanoma Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced funding for a new project aimed at improving the management of side effects caused …
NCCN Funds Research to Address Side Effects of PARP Inhibitors in Prostate Cancer Treatment Read More
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a cutting-edge gene-edited cell therapy aimed at treating relapsed and refractory (r/r) T …
Vittoria Biotherapeutics Launches Trial for Innovative T Cell Lymphoma Therapy Read More PHILADELPHIA, PA — The Wistar Institute has announced that two of its assistant professors, Dr. Nan Zhang and Dr. Noam Auslander, have been awarded a total of $1.2 million in …
Wistar Institute Researchers Secure $1.2 Million for Groundbreaking Cancer Studies Read More